Abstract: The invention provides a device comprising: at least one biocompatible polymer, and an eutectic composition comprising a first agent and an agent capable of forming a eutectic composition with the first agent; or one or more fatty acids; or one or more fatty alcohols; or one or more fatty amines or combinations thereof. The device can be administered to a subject in need thereof an effective amount of one or more active agents. The at least one biocompatible polymer may be selected from the group comprising poly ethylene-vinyl-acetate, vinyl acetate, silicone, polycaprolactone, polylacticco-glycolic acid, polylactic acid or polyglycolic acid.

Abstract: Provided are surfaces comprising particles, which particles may possess, for example, antimicrobial or biosensing properties. Also provided are related methods for fabrication of the inventive articles. Also provided are systems and methods for treating fluids, objects, and targets with the inventive surfaces.

Abstract: The present invention relates to a chewable formulation for delivering a nutritional or pharmaceutically active agent to an animal target. The chewable formulation comprises a nutritional ingredient or an effective amount of a pharmaceutically active agent, and a plasticizer. The chewable formulation is formed by extrusion and the formulation contains substantially no unbound water, nor is any water added in the manufacturing process. The present invention also relates to a method of manufacturing a shelf stable chewable formulation which comprises mixing the nutritional or pharmaceutically active agent with a fat, lipid or fat and lipid to obtain a first composition, adding one or more plasticizers to the first mixture to obtain a second composition, extruding the second composition at a temperature sufficient to melt the fat and lipid, and allowing the extruded second composition to cool to room temperature thereby providing the chewable formulation.

Abstract: The present invention relates to a chewable formulation for delivering a nutritional or pharmaceutically active agent to an animal target. The chewable formulation comprises a nutritional ingredient or an effective amount of a pharmaceutically active agent, and a plasticiser. The chewable formulation is formed by extrusion and the formulation contains substantially no unbound water, nor is any water added in the manufacturing process. The present invention also relates to a method of manufacturing a shelf stable chewable formulation which comprises mixing the nutritional or pharmaceutically active agent with a fat, lipid or fat and lipid to obtain a first composition, adding one or more plasticizers to the first mixture to obtain a second composition, extruding the second composition at a temperature sufficient to melt the fat and lipid, and allowing the extruded second composition to cool to room temperature thereby providing the chewable formulation.

Abstract: The present invention relates to a chewable formulation for delivering a nutritional or pharmaceutically active agent to an animal target. The chewable formulation comprises a nutritional ingredient or an effective amount of a pharmaceutically active agent, and a plasticizer. The chewable formulation is formed by extrusion and the formulation contains substantially no unbound water, nor is any water added in the manufacturing process. The present invention also relates to a method of manufacturing a shelf stable chewable formulation which comprises mixing the nutritional or pharmaceutically active agent with a fat, lipid or fat and lipid to obtain a first composition, adding one or more plasticizers to the first mixture to obtain a second composition, extruding the second composition at a temperature sufficient to melt the fat and lipid, and allowing the extruded second composition to cool to room temperature thereby providing the chewable formulation.

Abstract: The present invention relates to a chewable formulation for delivering a nutritional or pharmaceutically active agent to an animal target. The chewable formulation comprises a nutritional ingredient or an effective amount of a pharmaceutically active agent, and a plasticiser. The chewable formulation is formed by extrusion and the formulation contains substantially no unbound water, nor is any water added in the manufacturing process. The present invention also relates to a method of manufacturing a shelf stable chewable formulation which comprises mixing the nutritional or pharmaceutically active agent with a fat, lipid or fat and lipid to obtain a first composition, adding one or more plasticizers to the first mixture to obtain a second composition, extruding the second composition at a temperature sufficient to melt the fat and lipid, and allowing the extruded second composition to cool to room temperature thereby providing the chewable formulation.

Abstract: Particles are embedded in a substrate by applying to at least a portion of the substrate a fluid and a population of particles, such that the substrate is softened to at least a degree that particles are at least partially embedded in the softened portion of the substrate. The softened portion of the substrate is hardened so as to securely embed the particles in the substrate.

Abstract: Provided are surfaces comprising particles, which particles may possess, for example, antimicrobial or biosensing properties. Also provided are related methods for fabrication of the inventive articles. Also provided are systems and methods for treating fluids, objects, and targets with the inventive surfaces.

Abstract: Provided are surfaces comprising particles, which particles may possess, for example, antimicrobial or biosensing properties. Also provided are related methods for fabrication of the inventive articles. Also provided are systems and methods for treating fluids, objects, and targets with the inventive surfaces.

Abstract: An area efficient realization of an N-bit constant coefficient adder/subtractor implemented on FPGAs, utilizing N LUTs with single output generation capability. It includes three inputs from every LUT for addition/subtraction, without any requirement for extra logic for support of arithmetic mode and carry chains. For FPGAs supporting 4-input LUTs, the concept is further enhanced with the capability to perform addition and subtraction dynamically, by exploiting the fourth unused input of the LUTs. Another embodiment involves delay-optimized realization of an N-bit constant coefficient adder/subtractor implemented on FPGAs with 4-input LUTs. LUTs in the implementation have single output generation capability without any carry generation and propagation. The implementation utilizes N+1 LUTs and gives a delay proportional to N/2 of routing resource used. However, the implementation becomes more efficient by the use of cascade chains. The delay optimization is achieved by doing computation in two parallel chains.

Abstract: A system and method is disclosed for demodulating RF amplitude modulated signals in a demodulator circuit of an EPC0 compliant RFID tag. One advantageous embodiment of the invention comprises first and second input ports, a +ve envelope detector circuit for each of the first and second input ports, a ?ve envelope detector circuit for each of the first and second input ports, a +ve envelope differentiator circuit, a +ve low pass filter, a ?ve envelope differentiator circuit, a ?ve low pass filter, and a zero crossing detector. The zero crossing detector detects a transition in the RF input signal using a voltage difference between a +ve filtered differentiated envelope signal and a ?ve filtered differentiated envelope signal.

Abstract: An area efficient realization of an N-bit constant coefficient adder/subtractor implemented on FPGAs, utilizing N LUTs with single output generation capability. It includes three inputs from every LUT for addition/subtraction, without any requirement for extra logic for support of arithmetic mode and carry chains. For FPGAs supporting 4-input LUTs, the concept is further enhanced with the capability to perform addition and subtraction dynamically, by exploiting the fourth unused input of the LUTs. Another embodiment involves delay-optimized realization of an N-bit constant coefficient adder/subtractor implemented on FPGAs with 4-input LUTs. LUTs in the implementation have single output generation capability without any carry generation and propagation. The implementation utilizes N+1 LUTs and gives a delay proportional to N/2 of routing resource used. However, the implementation becomes more efficient by the use of cascade chains. The delay optimization is achieved by doing computation in two parallel chains.

Abstract: A system and method is disclosed for demodulating RF amplitude modulated signals in a demodulator circuit of an EPCO compliant RFID tag. One advantageous embodiment of the invention comprises first and second input ports, a +ve envelope detector circuit for each of the first and second input ports, a ?ve envelope detector circuit for each of the first and second input ports, a +ve envelope differentiator circuit, a +ve low pass filter, a ?ve envelope differentiator circuit, a ?ve low pass filter, and a zero crossing detector. The zero crossing detector detects a transition in the RF input signal using a voltage difference between a +ve filtered differentiated envelope signal and a ?ve filtered differentiated envelope signal.